Keeren Rameshchandra Shah - SEC Form 4 Insider Trading Activity
Chief Financial Officer
Summary
Updated Aug 16, 2026
Keeren Rameshchandra Shah has filed 1 SEC Form 4 filing across 1 company in the last 90 days.
Profile
Keeren Rameshchandra Shah serves as Chief Financial Officer of OKYO Pharma Ltd (OKYO). Shah has reported 1 insider filing with the SEC since 2026. The most recent filing was in June 2026.
- Role
- Chief Financial Officer
Board memberships
- OKYO Pharma Ltd
Trading Pattern
InsiderAlpha's records for Keeren Rameshchandra Shah go back to 2026: 1 primary Form 4 filing, an average of 1.0 per year. No transaction on record carries a Rule 10b5-1 flag - the filings look discretionary rather than pre-scheduled, which makes their timing more informative as a signal.
Career & Filing History
Every role Keeren Rameshchandra Shah has reported on a Form 4, reconstructed from the filings themselves. Reporting insiders must state their relationship to the issuer (officer title, director seat, or 10% ownership) on every filing.
- Chief Financial Officer at OKYO Pharma Ltd (OKYO) - 1 filing, 2026
Companies - Last 90 Days
1- OKYO Pharma Ltd (OKYO) - 1 filing, last 2026-06-10
Other Insiders Active in the Same Stocks
Insiders who reported open-market trades at the companies Keeren Rameshchandra Shah has recently filed at. Multiple unrelated insiders buying the same stock within a short window - cluster buying - has historically been one of the strongest Form 4 signals.
- Gabriele M. Cerrone - $35K of OKYO open-market activity in the last 12 months
- Flavio Mantelli - $28K of OKYO open-market activity in the last 12 months
- Robert John Dempsey - $23K of OKYO open-market activity in the last 12 months
- John P. Brancaccio - $7K of OKYO open-market activity in the last 12 months
- Rajkumar V. Patil - $5K of OKYO open-market activity in the last 12 months
- Gary S. Jacob - $5K of OKYO open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Keeren Rameshchandra Shah?
Keeren Rameshchandra Shah serves as Chief Financial Officer of OKYO Pharma Ltd (OKYO). Shah has reported 1 insider filing with the SEC since 2026. The most recent filing was in June 2026.…
How many SEC Form 4 filings has Keeren Rameshchandra Shah submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Where can I see all of Keeren Rameshchandra Shah's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Get alerts when Keeren Rameshchandra Shah files a new Form 4
Track every insider buy in real time, with AI-scored daily trade ideas and 10b5-1 plan flags.
Free during early access · No credit card required